miR-125b Inhibitor May Enhance the Invasion-Prevention Activity of Temozolomide in Glioblastoma Stem Cells by Targeting PIAS3
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-125b Inhibitor May Enhance the Invasion-Prevention Activity of Temozolomide in Glioblastoma Stem Cells by Targeting PIAS3
Authors
Keywords
Reverse Transcription Polymerase Chain Reaction, Temozolomide, Temozolomide Treatment, Glioblastoma Stem Cell, Chemotherapeutic Sensitivity
Journal
BIODRUGS
Volume 28, Issue 1, Pages 41-54
Publisher
Springer Nature
Online
2013-07-15
DOI
10.1007/s40259-013-0053-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sumoylation of Vimentin354 Is Associated with PIAS3 Inhibition of Glioma Cell Migration
- (2015) Oncotarget
- A Novel Inhibitor of STAT3 Homodimerization Selectively Suppresses STAT3 Activity and Malignant Transformation
- (2013) X. Zhang et al. CANCER RESEARCH
- MicroRNA-21 Inhibitor Sensitizes Human Glioblastoma U251 Stem Cells to Chemotherapeutic Drug Temozolomide
- (2012) Shuguang Zhang et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Functional Differences of miR-125b on the Invasion of Primary Glioblastoma CD133-Negative Cells and CD133-Positive Cells
- (2012) Lei Shi et al. NEUROMOLECULAR MEDICINE
- Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3
- (2012) Yi Wan et al. Chinese Journal of Cancer
- MicroRNA-146a Inhibits Glioma Development by Targeting Notch1
- (2011) J. Mei et al. MOLECULAR AND CELLULAR BIOLOGY
- Pharmacogenomics genes show varying perceptibility to microRNA regulation
- (2011) Jakob Lewin Rukov et al. Pharmacogenetics and Genomics
- High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) R. Stupp et al. ANNALS OF ONCOLOGY
- MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol
- (2010) Yu Ren et al. BMC CANCER
- Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells
- (2010) Christian Senft et al. JOURNAL OF NEURO-ONCOLOGY
- MicroRNAs and pharmacogenomics
- (2010) Noam Shomron PHARMACOGENOMICS
- Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer
- (2010) S. Cairo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation
- (2009) Lei Shi et al. BRAIN RESEARCH
- MiR-125b Expression Affects the Proliferation and Apoptosis of Human Glioma Cells by Targeting Bmf
- (2009) Hong-Fei Xia et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines
- (2009) M. J. Clarke et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine
- (2009) Prasun J Mishra et al. PHARMACOGENOMICS
- Loss of Protein Inhibitors of Activated STAT-3 Expression in Glioblastoma Multiforme Tumors: Implications for STAT-3 Activation and Gene Expression
- (2008) E. C. Brantley et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now